NCT01615393View on ClinicalTrials.gov

A Study to Compare the Bioavailability of Copegus and Vilona® in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
Healthy Volunteer
Interventions
DRUG

ribavirin [Copegus]

Single oral dose of 400 mg tablets

DRUG

ribavirin [Vilona]

Single oral dose of a 400 mg capsule

Trial Locations (1)

58249

Morelia

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01615393 - A Study to Compare the Bioavailability of Copegus and Vilona® in Healthy Volunteers | Biotech Hunter | Biotech Hunter